SiriusPoint Ltd: Form 10-Q for the period ended Sep 30, 2025
Filed with the SEC on Oct 30, 2025 and accepted by EDGAR at Oct 30, 2025, 16:20 ET.
Management's discussion and analysis
As filed, 87,172 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with our unaudited consolidated financial statements and the related notes contained elsewhere in this Quarterly Report on Form 10-Q (“Form 10-Q”) and the information under "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. The terms “we,” “our,” “us” and the “Company,” as used in this report, refer to SiriusPoint Ltd. (“SiriusPoint”) and its directly and indirectly owned subsidiaries as a combined entity, except where otherwise stated or where it is clear that the terms mean only SiriusPoint exclusive of its subsidiaries.
The statements in this discussion regarding business outlook, our expectations regarding our future performance, liquidity and capital resources and other non-historical statements in this discussion are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described in “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2024 (the “2024 Form 10-K”) and in “Cautionary Note Regarding Forward-Looking Statements” below. Our actual results may differ materially from those contained in or implied by any forward-looking statements.
Cautionary Note Regarding Forward-Looking Statements
Certain statements in this Form 10-Q may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements regarding prospects for our industry, our business strategy, plans, goals and expectations concerning our market position, international expansion, investment portfolio expectations, future operations, margins, profitability, efficiencies, capital expenditures, liquidity and capital resources and other non-historical financial and operating information. When used in this discussion, the words “believes,” “intends,” “seeks,” “anticipates,” “aims,” “plans,” “targets,” “estimates,” “expects,” “assumes,” “continues,” “should,” “could,” “will,” “may” and the negative of these or similar terms and phrases are intended to identify forward-looking statements. Specific forward-looking statements in this Form 10-Q include, but are not limited to, statements regarding the trend of our performance as compared to the previous guidance, the current insurtech market trends, our ability to generate shareholder value, and whether we will continue to have momentum in our business in the future.
Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to have been correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, the following:
- our ability to execute on our strategic transformation, including re-underwriting to reduce volatility and improve underwriting performance, de-risking our investment portfolio, and transforming our business;
- the impact of unpredictable catastrophic events, including uncertainties with respect to losses from health pandemics across many classes of insurance business and the amount of insurance losses that may ultimately be ceded to the reinsurance market, supply chain issues, labor shortages and related increased costs, changing interest rates and equity market volatility;
- inadequacy of loss and loss adjustment expense reserves, the lack of available capital, and periods characterized by excess underwriting capacity and unfavorable premium rates;
- the performance of financial markets, impact of inflation and interest rates, and foreign currency fluctuations;
- our ability to compete successfully in the insurance and reinsurance market and the effect of consolidation in the insurance and reinsurance industry;
- technology breaches or failures, including those resulting from a malicious cyber-attack on us, our business partners or service providers;
- the effects of global climate change, including wildfires, and increased severity and frequency of weather-related natural disasters and catastrophes and increased coastal flooding in many geographic areas;
- geopolitical uncertainty, including the ongoing conflicts in Europe and the Middle East and the uncertainty from policies under the current presidential administration in the U.S., such as the federal government shutdown and financial markets’ and business reactions to such events;
- global economic uncertainty caused by the imposition and/or announcement of tariffs imposed on the import of certain goods into the U.S. from various countries which may have unpredictable consequences including, but not limited to, inflation or trade wars, potential impact on the Company’s credit and mortgage business and potential increase in credit spreads which could impact the Company’s short-term capital and liquidity;
- our ability to retain key senior management and key employees;
- a downgrade or withdrawal of our financial ratings;
- fluctuations in our results of operations;
- legal restrictions on certain of SiriusPoint’s insurance and reinsurance subsidiaries’ ability to pay dividends and other distributions to SiriusPoint;
- the outcome of legal and regulatory proceedings and regulatory constraints on our business;
- reduced returns or losses in SiriusPoint’s investment portfolio;
- our exposure or potential exposure to corporate income tax in Bermuda and the E.U., U.S. federal income and withholding taxes and our significant deferred tax assets, which could become devalued if we do not generate future taxable income or applicable corporate tax rates are reduced;
- risks associated with delegating authority to third party managing general agents (“MGAs”);
- future strategic transactions such as acquisitions, dispositions, investments, mergers or joint ventures; and
- other risks and factors listed under “Risk Factors” in our 2024 Form 10-K and other subsequent periodic reports filed with the Securities and Exchange Commission.
Any one of these factors or a combination of these factors could materially affect our financial condition or future results of operations and could influence whether any forward-looking statements contained in this report ultimately prove to be accurate. Our forward-looking statements are not guarantees of future performance, and you should not place undue reliance on them. All forward-looking statements speak only as of the date made and we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
In addition, while we do, from time to time, communicate with security analysts, it is against our policy to disclose to them any material non-public information or other confidential information. Accordingly, shareholders should not assume that we agree with any statement or report issued by any analyst irrespective of the content of the statement or report. Thus, to the extent that reports issued by securities analysts contain any projections, forecasts, or opinions, such reports are not our responsibility.
Overview
We are a global underwriter of insurance and reinsurance, domiciled in Bermuda. We have licenses to write property, casualty and accident & health insurance and reinsurance globally, including admitted & non-admitted licensed companies in the United States, a Bermuda Class 4 company, a Lloyd’s of London (“Lloyd’s”) syndicate and managing agency, and an internationally licensed company domiciled in Sweden. Our operating companies have a financial strength rating of A- (Positive) from AM Best, Fitch Ratings (“Fitch”) and Standard & Poor's (“S&P”) and A3 (Stable) from Moody’s Ratings (“Moody’s”).
We are an underwriting first company as we aim to create a business model which is simplified, fully-integrated and globally connected. Distribution relationships are important to us, as we generate premiums from various carefully selected partners, including our consolidated MGAs and non-consolidated MGAs. We seek to apply our underwriting talent, capabilities and proven management expertise to underwrite a profitable book of business and identify new opportunities to create value. Our approach is to be nimble and reactive to market opportunities within our segments of Insurance & Services and Reinsurance, allocating capital where we see profitable opportunity, while remaining disciplined and consistent within our specified risk tolerances and areas of expertise. Our MGA strategy is to partner with high integrity and transparent leaders and teams with deep underwriting expertise and a track record of success. Our partnerships are structured to incentivize all parties to deliver thereby allowing capable teams to do what they do best, while providing complementary services. As of September 30, 2025, we had equity stakes in 20 entities (MGAs, Insurtech and Other) which underwrite or distribute a wide range of lines of business, including general liability, professional liability, directors & officers, credit and bond, commercial automobile, workers’ compensation, accident & health, and other specialty insurance classes.
Products & Services
Insurance & Services Segment
In our Insurance & Services segment, we predominantly provide insurance coverage in addition to receiving fees for services provided within Insurance & Services and to third parties. Insurance & Services revenue allows us to diversify our traditional reinsurance portfolio and generally has lower capital requirements. In addition, service fees from MGAs and their insurance provided are generally not as prone to the volatile underwriting cycle that is common in reinsurance marketplace. The Insurance & Services segment provides coverage in Accident & Health (“A&H”), Property & Casualty, and Other Specialties.
Reinsurance Segment
In our Reinsurance segment, we provide reinsurance products to insurance and reinsurance companies, government entities, and other risk bearing vehicles on a treaty or facultative basis. For reinsurance assumed, we participate in the reinsurance market with a global focus through the broker market distribution channel. We primarily write treaty reinsurance, on both a proportional and excess of loss basis, and provide facultative reinsurance in some of our business lines. In the United States and Bermuda, our core focus is on distribution, risk and clients located in North America while our international operation is focused primarily on distribution, risks and clients located in Europe. The Reinsurance segment predominantly underwrites Casualty, Property and Other Specialties lines of business on a worldwide basis.
Investment Management
We manage our investment portfolio to balance quality, liquidity, and diversification with asset/liability matching and investment return. Our investment objective is to optimize risk-adjusted net investment income after tax while (1) maintaining a high quality, diversified investment portfolio, (2) maintaining adequate liquidity, and (3) complying with the regulatory, rating agency, and internal risk and capital management requirements, all in support of the company goal of meeting policyholder obligations.
Recent Developments
Sale of Armada
On September 29, 2025 the Company entered into an agreement to sell its wholly owned subsidiary, ArmadaCorp Capital, LLC (“Armada”), to Ambac Financial Group Inc. for $250 million. SiriusPoint will continue its capacity partnership with Armada until the end of 2030. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions and receipt of regulatory approvals. Upon completion of the transaction, the Company is expected to recognize a pre-tax gain of $220 million to $230 million.
Sale of Arcadian
On October 3, 2025 the Company entered into an agreement to sell its 49% equity stake in managing general agent, Arcadian Holdings Limited (“Arcadian”), to Lee Equity Partners for total consideration of $139 million, inclusive of a pre-close dividend. The Company has also renewed and extended its capacity agreement with Arcadian until the end of 2031. The transaction is expected to close prior to the end of the first quarter of 2026, subject to regulatory approvals and satisfaction of customary closing conditions. Upon completion of the transaction, the Company is expected to recognize a pre-tax gain of $25 million to $30 million.
Ratings
On March 5, 2025, April 25, 2025 and October 2, 2025, Fitch, AM Best and S&P, respectively, affirmed our ratings and revised our outlook to Positive from Stable. These revisions reflect our improved balance sheet strength, continued underwriting performance improvement and reduced risk profile.
Key Performance Indicators
We believe that the following key financial indicators are the most important in evaluating our performance for the three and nine months ended September 30, 2025 and 2024, and as of September 30, 2025 and December 31, 2024:
($ in millions, except for ratios)
| Three months ended September 30, 2025 | September 30, 2024 | Nine months ended September 30, 2025 | September 30, 2024 | |
|---|---|---|---|---|
| Combined ratio | 85.9% | 84.4% | 87.8% | 86.1% |
| Core underwriting income ⁽¹⁾ | $69.6 | $62.5 | $165.7 | $143.7 |
| Core net services income ⁽¹⁾ | $10.1 | $7.0 | $37.7 | $34.2 |
| Core income ⁽¹⁾ | $79.7 | $69.5 | $203.4 | $177.9 |
| Core combined ratio ⁽¹⁾ | 89.1% | 88.5% | 91.4% | 91.1% |
| Annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders | 17.7% | 0.7% | 14.5% | 11.4% |
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Book value per common share | $17.21 | $14.92 |
| Book value per diluted common share | $16.91 | $14.60 |
| Tangible book value per diluted common share ⁽¹⁾ | $15.87 | $13.42 |
(1) Core underwriting income, Core net services income, Core income and Core combined ratio are non-GAAP financial measures. See definitions in “Non-GAAP Financial Measures” and reconciliations in “Segment Results” below and Note 4 “Segment reporting” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q. Tangible book value per diluted common share is a non-GAAP financial measure. See definition and reconciliation in “Non-GAAP Financial Measures.”
Core Results
See “Segment Results” below for additional information.
Annualized Return on Average Common Shareholders’ Equity Attributable to SiriusPoint Common Shareholders
Annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders is calculated by dividing annualized net income available to SiriusPoint common shareholders for the period by the average common shareholders’ equity determined using the common shareholders’ equity balances at the beginning and end of the period.
Annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders for the three and nine months ended September 30, 2025 and 2024 was calculated as follows:
($ in millions)
| Three months ended September 30, 2025 | September 30, 2024 | Nine months ended September 30, 2025 | September 30, 2024 | |
|---|---|---|---|---|
| Net income available to SiriusPoint common shareholders | $86.8 | $4.5 | $203.6 | $205.2 |
| Common shareholders’ equity attributable to SiriusPoint common shareholders - beginning of period | 1,905.7 | 2,504.1 | 1,737.4 | 2,313.9 |
| Common shareholders’ equity attributable to SiriusPoint common shareholders - end of period | 2,009.9 | 2,494.9 | 2,009.9 | 2,494.9 |
| Average common shareholders’ equity attributable to SiriusPoint common shareholders | $1,957.8 | $2,499.5 | $1,873.7 | $2,404.4 |
| Annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders | 17.7% | 0.7% | 14.5% | 11.4% |
KPI
The increase in annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders was driven by higher net income for the three months ended September 30, 2025, due to the 2024 loss on the settlement of liability classified instruments of $117.3 million, partially offset by lower net investment income.
The increase in annualized return on average common shareholders’ equity attributable to SiriusPoint common shareholders for the nine months ended September 30, 2025 is the result of consistent net income combined with a decrease in shareholders’ equity subsequent to the share repurchases in the fourth quarter of 2024 and first quarter of 2025.
Book Value Per Share
Book value per common share is calculated by dividing common shareholders’ equity attributable to SiriusPoint common shareholders by the number of common shares outstanding. Book value per diluted common share is calculated by dividing common shareholders’ equity attributable to SiriusPoint common shareholders by the number of diluted common shares outstanding, calculated similar to the treasury stock method.
Tangible book value per diluted common share is a non-GAAP financial measure and the most comparable U.S. GAAP measure is book value per common share. See “Non-GAAP Financial Measures” for an explanation and reconciliation.
As of September 30, 2025, book value per common share was $17.21, representing an increase of $0.89 per share, or 5.5%, from $16.32 per share as of June 30, 2025. As of September 30, 2025, book value per diluted common share was $16.91, representing an increase of $0.88 per share, or 5.5%, from $16.03 per share as of June 30, 2025. As of September 30, 2025, tangible book value per diluted common share was $15.87, representing an increase of $0.98 per share, or 6.6%, from $14.89 per share as of June 30, 2025.
As of September 30, 2025, book value per common share was $17.21, representing an increase of $2.29 per share, or 15.3%, from $14.92 per share as of December 31, 2024. As of September 30, 2025, book value per diluted common share was $16.91, representing an increase of $2.31 per share, or 15.8%, from $14.60 per share as of December 31, 2024. As of September 30, 2025, tangible book value per diluted common share was $15.87, representing an increase of $2.45 per share, or 18.3%, from $13.42 per share as of December 31, 2024.
The increases reflect continued positive underwriting and investment results during the three and nine months ended September 30, 2025.
Consolidated Results of Operations—Three and nine months ended September 30, 2025 and 2024
The following table sets forth the key items discussed in the consolidated results of operations section, and the period over period change, for the three and nine months ended September 30, 2025 and 2024:
($ in millions)
| Three months ended September 30, 2025 | September 30, 2024 | Change | Nine months ended September 30, 2025 | September 30, 2024 | Change | |
|---|---|---|---|---|---|---|
| Total underwriting income | $91.4 | $89.0 | $2.4 | $235.7 | $243.7 | $(8.0) |
| Net investment income and net realized and unrealized investment gains (losses) | 72.7 | 92.5 | (19.8) | 212.5 | 195.6 | 16.9 |
| Other revenues | 35.5 | 18.1 | 17.4 | 92.5 | 164.8 | (72.3) |
| Loss on settlement and change in fair value of liability-classified capital instruments | — | (117.3) | 117.3 | — | (122.6) | 122.6 |
| Net corporate and other expenses | (62.5) | (51.4) | (11.1) | (194.0) | (174.0) | (20.0) |
| Intangible asset amortization | (2.8) | (3.0) | 0.2 | (8.5) | (8.9) | 0.4 |
| Interest expense | (21.0) | (13.8) | (7.2) | (60.2) | (50.0) | (10.2) |
| Foreign exchange losses | (2.4) | (3.0) | 0.6 | (16.9) | (2.9) | (14.0) |
| Income tax expense | (20.2) | (2.4) | (17.8) | (45.1) | (26.3) | (18.8) |
| Net income | $90.7 | $8.7 | $82.0 | $216.0 | $219.4 | $(3.4) |
42
The key changes in our consolidated results for the three and nine months ended September 30, 2025 compared to the prior year periods are discussed below.
Underwriting results
The improvement in net underwriting results for the three months ended September 30, 2025 compared to the three months ended September 30, 2024 was primarily driven by premium growth at a lower attritional loss ratio and a decrease in catastrophe losses of $10.6 million offset by a decrease in favorable prior year development of $21.7 million.
The decrease in net underwriting results for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 was primarily driven by increased catastrophe losses from the California wildfires, partially offset by a decrease in attritional loss ratio.
Investments
Investment Portfolio
The following table presents the carrying value of our total investments, cash and cash equivalents and restricted cash and cash equivalents as of September 30, 2025 and December 31, 2024:
($ in millions)
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Debt securities, available for sale | $5,145.6 | $5,131.0 |
| Debt securities, trading | 98.7 | 162.2 |
| Total debt securities (1) | 5,244.3 | 5,293.2 |
| Short-term investments | 24.6 | 95.8 |
| Other long-term investments | 318.3 | 316.5 |
| Total investments | 5,587.2 | 5,705.5 |
| Cash and cash equivalents | 582.4 | 682.0 |
| Restricted cash and cash equivalents (2) | 135.3 | 212.6 |
| Total invested assets and cash (1) | $6,304.9 | $6,600.1 |
(1) Includes $653.5 million of investments in the Third Point Optimized Credit portfolio (“TPOC Portfolio”) as of September 30, 2025 (December 31, 2024 - $595.8 million).
(2) Primarily consists of cash and fixed income securities such as U.S. Treasuries, money markets funds, and sovereign debt, securing our contractual obligations under certain (re)insurance contracts that we will not be released from until the underlying risks have expired or have been settled.
The decrease in total invested assets and cash was primarily driven by the use of $483.0 million of investments to fund the share repurchase from CM Bermuda Limited (“CM Bermuda”) under a securities purchase agreement entered into in December 2024, partially offset by a $54.0 million gain on the AFS portfolio, primarily driven by changes in the Federal Reserve’s monetary policies, and reinvestment of cash generated from investment income and underwriting operations.
The duration of our fixed income portfolio, excluding cash and cash equivalents, is 3.1 years (December 31, 2024 - 3.1 years). The duration remained consistent from the comparative period due to our efforts to match our asset duration with economic liabilities in the current interest rate environment. The average credit rating of our investment portfolio is “AA-” as of September 30, 2025 (December 31, 2024 - “AA-”) with no defaults in the investment portfolio.
The following table provides a breakdown of structured products between investment and non-investment grade securities as of September 30, 2025 and December 31, 2024. These are fixed income investments which are included in debt securities in the table above. Refer to Note 7 “Investments” to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for further discussion of these securities.
($ in millions)
| September 30, 2025 Investment Grade (1) | Non-investment Grade (2) | December 31, 2024 Investment Grade (1) | Non-investment Grade (2) | |
|---|---|---|---|---|
| Asset-backed securities | $578.6 | $18.7 | $719.4 | $33.7 |
| Collateralized loan obligations | 325.8 | — | 447.5 | 2.2 |
| Total asset-backed securities | 904.4 | 18.7 | 1,166.9 | 35.9 |
| Agency residential mortgage-backed securities | 807.0 | — | 852.2 | — |
| Non-agency residential mortgage-backed securities | 190.7 | 23.0 | 159.1 | 11.2 |
| Total residential mortgage-backed securities | 997.7 | 23.0 | 1,011.3 | 11.2 |
| Agency commercial mortgage-backed securities | 48.3 | — | 48.6 | — |
| Non-agency commercial mortgage-backed securities | 191.7 | 0.5 | 226.8 | 0.9 |
| Total commercial mortgage-backed securities | 240.0 | 0.5 | 275.4 | 0.9 |
| Total mortgage-backed securities | 1,237.7 | 23.5 | 1,286.7 | 12.1 |
| Total asset and mortgage-backed securities | $2,142.1 | $42.2 | $2,453.6 | $48.0 |
(1) Investment grade securities are considered rated BBB or higher.
(2) Non-investment grade securities are considered rated below BBB.
Investment Results
The following is a summary of the results from investments and cash for the three and nine months ended September 30, 2025 and 2024:
($ in millions)
| Three months ended September 30, 2025 | September 30, 2024 | Nine months ended September 30, 2025 | September 30, 2024 | |
|---|---|---|---|---|
| Gross investment income | $71.4 | $85.1 | $219.8 | $253.6 |
| Change in fair value of trading portfolio (1) | 2.1 | 7.2 | 11.3 | (23.4) |
| Net realized investment gains (losses) | 4.1 | 7.6 | (4.7) | (15.7) |
| Investment results | 77.6 | 99.9 | 226.4 | 214.5 |
| Investment expenses | (4.9) | (7.4) | (13.9) | (18.9) |
| Total net investment income and net realized and unrealized investment gains (losses) | $72.7 | $92.5 | $212.5 | $195.6 |
(1) Trading portfolio is inclusive of all non-AFS designated investments in the investment portfolio.
The following is a summary of the results from investments by investment classification for the three and nine months ended September 30, 2025 and 2024:
($ in millions)
| Three months ended September 30, 2025 | September 30, 2024 | Nine months ended September 30, 2025 | September 30, 2024 | |
|---|---|---|---|---|
| Debt securities, available for sale | $72.3 | $71.6 | $190.8 | $196.9 |
| Debt securities, trading | 3.6 | 8.1 | 9.9 | 22.5 |
| Short-term investments | 0.4 | 1.8 | 1.4 | 9.1 |
| Other long-term investments | (4.2) | 7.1 | 1.6 | (41.1) |
| Derivative instruments | 0.3 | 3.7 | (0.2) | 5.4 |
| Net investment income and net realized and unrealized investment gains (losses) before other investment expenses and investment income on cash and cash equivalents | 72.4 | 92.3 | 203.5 | 192.8 |
| Investment expenses | (4.9) | (7.4) | (13.9) | (18.9) |
| Net investment income on cash and cash equivalents | 5.2 | 7.6 | 22.9 | 21.7 |
| Net investment income and net realized and unrealized investment gains (losses) | $72.7 | $92.5 | $212.5 | $195.6 |
Net investment income and net realized and unrealized investment gains (losses) for the three months ended September 30, 2025 decreased as a result of the smaller asset base subsequent to the capital transactions executed in the second half of 2024 and the first quarter of 2025.
Net investment income and net realized and unrealized investment gains (losses) for the nine months ended September 30, 2025 increased due to losses on strategic investments in 2024 of $56.2 million resulting from the Company’s recurring valuations of its portfolio. Excluding the losses on strategic investments and other items, the primary components of income for the nine months ended September 30, 2025 and September 30, 2024 were $202.1 million and $228.5 million, respectively, on our debt securities and short-term investments. The year over year decrease is a result of the smaller asset base subsequent to the capital transactions executed in the second half of 2024 and the first quarter of 2025.
Refer to Part I, Item 3. “Quantitative and Qualitative Disclosures about Market Risks” of this Form 10-Q for a discussion of certain risks and factors that could adversely impact our investments results.
Other Revenues
For the three months ended September 30, 2025, other revenues primarily consisted of $25.8 million of service fee revenue from MGAs in addition to a non-recurring $11.0 million insurance recovery related to a legacy litigation, compared to $18.2 million of service fee revenue from MGAs for the three months ended September 30, 2024. The increase in service fee revenue for the three months ended September 30, 2025 compared to the three months ended September 30, 2024 is primarily driven by increases in the travel insurance business of International Medical Group, Inc. (“IMG”).
For the nine months ended September 30, 2025, other revenues primarily consisted of $84.1 million of service fee revenue from MGAs in addition to a non-recurring $11.0 million insurance recovery related to a legacy litigation compared to a gain of $95.9 million from the deconsolidation of Arcadian and $69.9 million of service fee revenue from MGAs for the nine months ended September 30, 2024. The increase in service fee revenue for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 is primarily driven by increases in IMG’s travel insurance business, partially offset by a decrease from the deconsolidation of Arcadian.
Loss on Settlement and Change in Fair Value of Liability Classified Instruments
For the three and nine months ended September 30, 2025, we did not incur a loss on settlement and change in fair value of liability classified instruments as all instruments were previously settled or exercised, compared to a loss of $117.3 million and $122.6 million for the three and nine months ended September 30, 2024, respectively, driven by the settlement of the
Series A preference shares under the CMIG Agreement and the change in fair value of the Merger Warrants primarily driven by changes in our share price.
Net Corporate and Other Expenses
Net corporate and other expenses include costs associated with operating as a publicly-traded company and non-underwriting activities, including services expenses from our MGA subsidiaries, and current expected credit losses from our insurance and reinsurance balances receivable and loss and loss adjustment expenses recoverable.
The increase in net corporate and other expenses for the three and nine months ended September 30, 2025 compared to the three and nine months ended September 30, 2024 was primarily driven by increases in service expenses and expenses associated with non-recurring projects.
For the three months ended September 30, 2025, services expenses increased to $48.5 million compared to $41.3 million for the three months ended September 30, 2024, primarily driven by increases in expenses proportional to IMG revenue growth.
For the nine months ended September 30, 2025 services expenses increased to $141.2 million compared to $135.0 million for the nine months ended September 30, 2024, primarily driven by increases in expenses related to IMG, slightly offset by decreases from the deconsolidation of Arcadian.
Amortization of Intangible Assets
Amortization of intangible assets for the three and nine months ended September 30, 2025 was $2.8 million and $8.5 million, respectively (2024 - $3.0 million and $8.9 million, respectively). The changes in amortization are due to the use of amortization patterns which are based on the period over which they are expected to generate future net cash inflows from the use of the underlying intangible assets.
Interest Expense
Interest expense and finance costs are related to interest due on our senior and subordinated notes, as well as interest associated with certain reinsurance contracts.
Interest expense for the three and nine months ended September 30, 2025 was $21.0 million and $60.2 million, respectively, compared to $13.8 million and $50.0 million for the three and nine months ended September 30, 2024. The increases were primarily driven by funds withheld interest on the loss portfolio transfer with Clarendon National Insurance Company which was completed in October 2024 (the “2024 LPT”) and included in the three and nine months ended September 30, 2025.
Foreign Currency Translation
Except for the Canadian reinsurance operations of SiriusPoint America and certain subsidiaries of IMG, the U.S. dollar is the functional currency for our business. Assets and liabilities are remeasured into the functional currency using current exchange rates; revenues and expenses are remeasured into the functional currency using the average exchange rate for the period. The remeasurement process results in foreign exchange (gains) losses in the consolidated results of operations. Foreign exchange (gains) losses exclude investment generated net realized and unrealized investment gains as addressed in Investment Results above.
The foreign exchange losses for the three and nine months ended September 30, 2025 of $2.4 million and $16.9 million, respectively, were primarily driven by the impact of certain foreign exchange exposures related to our underwriting activities, partially offset by the impact of our currency hedges.
The foreign exchange losses of $3.0 million for the three months ended September 30, 2024 were primarily due to $3.7 million of foreign exchange losses from our international operations. The foreign exchange losses of $2.9 million for the nine months ended September 30, 2024 were primarily due to $1.0 million of foreign exchange losses from our international operations.
In addition to the foreign exchange losses noted above, foreign currency losses for the three and nine months ended September 30, 2025 of $0.8 million and $3.0 million, respectively, were recorded as part of investments results. See Note 8 “Total net investment income and net realized and unrealized investment gains (losses)” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
On an aggregate basis, the effects of foreign exchange resulted in charges to net income of $2.6 million and $18.3 million as well as charges (benefits) to comprehensive income of $(3.1) million and $1.9 million for the three and nine months ended September 30, 2025, respectively. The effects of foreign exchange are consistent with the recent market fluctuations in rates and the Company’s economic currency hedging strategy.
Income Tax Expense
The increases in income tax expense for the three and nine months ended September 30, 2025 compared to the three and nine months ended September 30, 2024 were consistent with the increases in pre-tax income.
Segment Results — Three and nine months ended September 30, 2025 and 2024
The determination of our reportable segments is based on the manner in which management monitors the performance of our operations. We classify our business into two reportable segments - Insurance & Services and Reinsurance. Collectively, the sum of these two segments constitute “Core” results. Core underwriting income, Core net services income, Core income and Core combined ratio are non-GAAP financial measures. We believe it is useful to review Core results as it better reflects how management views the business and reflects our decision to exit the runoff business. The sum of Core results and Corporate results are equal to the consolidated results of operations.
Corporate results include all runoff business, which represents certain classes of business that we no longer actively underwrite, including the effect of the restructuring of the underwriting platform announced in 2022 (the “Restructuring Plan”) and certain reinsurance contracts that have interest crediting features. Corporate results include asbestos and environmental and other latent liability exposures on a gross basis, which have mostly been ceded, as well as specific workers’ compensation and cyber programs which we no longer write.
The following tables set forth the operating segment results and ratios for the three months ended September 30, 2025 and 2024:
($ in millions)
| Three months ended September 30, 2025 Insurance & Services | Reinsurance | Core | Eliminations (2) | Corporate | Segment Measure Reclass | Total | |
|---|---|---|---|---|---|---|---|
| Gross premiums written | $562.0 | $309.6 | $871.6 | $— | $2.8 | $— | $874.4 |
| Net premiums written | 396.8 | 268.1 | 664.9 | — | 5.4 | — | 670.3 |
| Net premiums earned | 381.2 | 262.3 | 643.5 | — | 4.2 | — | 647.7 |
| Loss and loss adjustment expenses incurred, net | 225.3 | 145.5 | 370.8 | (1.5) | 3.6 | — | 372.9 |
| Acquisition costs, net | 98.3 | 64.7 | 163.0 | (26.9) | 3.7 | — | 139.8 |
| Other underwriting expenses | 19.9 | 20.2 | 40.1 | — | 3.5 | — | 43.6 |
| Underwriting income (loss) | 37.7 | 31.9 | 69.6 | 28.4 | (6.6) | — | 91.4 |
| Services revenues | 58.5 | — | 58.5 | (32.7) | — | (25.8) | — |
| Services expenses | 48.5 | — | 48.5 | — | — | (48.5) | — |
| Net services fee income | 10.0 | — | 10.0 | (32.7) | — | 22.7 | — |
| Services noncontrolling loss | 0.1 | — | 0.1 | — | — | (0.1) | — |
| Net services income | 10.1 | — | 10.1 | (32.7) | — | 22.6 | — |
| Segment income (loss) | $47.8 | $31.9 | $79.7 | $(4.3) | $(6.6) | $22.6 | $91.4 |
| Attritional losses | $234.8 | $145.1 | $379.9 | $(1.5) | $3.4 | $— | $381.8 |
| Catastrophe losses | — | — | — | — | — | — | — |
| Prior year loss reserve development | (9.5) | 0.4 | (9.1) | — | 0.2 | — | (8.9) |
| Loss and loss adjustment expenses incurred, net | $225.3 | $145.5 | $370.8 | $(1.5) | $3.6 | $— | $372.9 |
| Underwriting Ratios: (1) | |||||||
| Attritional loss ratio | 61.6% | 55.3% | 59.0% | 59.0% | |||
| Catastrophe loss ratio | —% | —% | —% | —% | |||
| Prior year loss development ratio | (2.5)% | 0.2% | (1.4)% | (1.4)% | |||
| Loss ratio | 59.1% | 55.5% | 57.6% | 57.6% | |||
| Acquisition cost ratio | 25.8% | 24.7% | 25.3% | 21.6% | |||
| Other underwriting expenses ratio | 5.2% | 7.7% | 6.2% | 6.7% | |||
| Combined ratio | 90.1% | 87.9% | 89.1% | 85.9% |
(1) Underwriting ratios are calculated by dividing the related expense by net premiums earned.
(2) Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.
($ in millions)
| Three months ended September 30, 2024 Insurance & Services | Reinsurance | Core | Eliminations (2) | Corporate | Segment Measure Reclass | Total | |
|---|---|---|---|---|---|---|---|
| Gross premiums written | $376.0 | $314.5 | $690.5 | $— | $23.5 | $— | $714.0 |
| Net premiums written | 235.3 | 268.3 | 503.6 | — | 0.6 | — | 504.2 |
| Net premiums earned | 276.9 | 269.4 | 546.3 | — | 22.6 | — | 568.9 |
| Loss and loss adjustment expenses incurred, net | 170.1 | 137.6 | 307.7 | (1.4) | 11.2 | — | 317.5 |
| Acquisition costs, net | 65.9 | 69.8 | 135.7 | (24.1) | 5.9 | — | 117.5 |
| Other underwriting expenses | 20.0 | 20.4 | 40.4 | — | 4.5 | — | 44.9 |
| Underwriting income | 20.9 | 41.6 | 62.5 | 25.5 | 1.0 | — | 89.0 |
| Services revenues | 48.1 | — | 48.1 | (29.9) | — | (18.2) | — |
| Services expenses | 41.3 | — | 41.3 | — | — | (41.3) | — |
| Net services fee income | 6.8 | — | 6.8 | (29.9) | — | 23.1 | — |
| Services noncontrolling loss | 0.2 | — | 0.2 | — | — | (0.2) | — |
| Net services income | 7.0 | — | 7.0 | (29.9) | — | 22.9 | — |
| Segment income | $27.9 | $41.6 | $69.5 | $(4.4) | $1.0 | $22.9 | $89.0 |
| Attritional losses | $183.9 | $142.9 | $326.8 | $(1.4) | $12.1 | $— | $337.5 |
| Catastrophe losses | (0.7) | 11.3 | 10.6 | — | — | — | 10.6 |
| Prior year loss reserve development | (13.1) | (16.6) | (29.7) | — | (0.9) | — | (30.6) |
| Loss and loss adjustment expenses incurred, net | $170.1 | $137.6 | $307.7 | $(1.4) | $11.2 | $— | $317.5 |
| Underwriting Ratios: (1) | |||||||
| Attritional loss ratio | 66.4% | 53.1% | 59.8% | 59.3% | |||
| Catastrophe loss ratio | (0.3)% | 4.2% | 1.9% | 1.9% | |||
| Prior year loss development ratio | (4.7)% | (6.2)% | (5.4)% | (5.4)% | |||
| Loss ratio | 61.4% | 51.1% | 56.3% | 55.8% | |||
| Acquisition cost ratio | 23.8% | 25.9% | 24.8% | 20.7% | |||
| Other underwriting expenses ratio | 7.2% | 7.6% | 7.4% | 7.9% | |||
| Combined ratio | 92.4% | 84.6% | 88.5% | 84.4% |
(1) Underwriting ratios are calculated by dividing the related expense by net premiums earned.
(2) Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.
Core Premium Volume
Gross premiums written increased by $181.1 million, or 26.2%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. Net premiums written increased by $161.3 million, or 32.0%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. Net premiums earned increased by $97.2 million, or 17.8%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The increases in premium volume were primarily driven by our Insurance & Services segment, including expansion of Surety within our Other Specialties business line, growth across A&H including Life, and continued strategic organic and new program growth in our international P&C business.
Core Underwriting Results
The improvement in net underwriting results of $7.1 million was primarily driven by premium growth coupled with a slight improvement in attritional losses as well as decreased catastrophe losses, offset by a decrease in favorable prior year development. Effects of catastrophes were limited for the three months ended September 30, 2025, compared to $10.6 million of catastrophe losses for the three months ended September 30, 2024. For the three months ended September 30, 2025 favorable prior year loss reserve development was $9.1 million primarily driven by favorable development in A&H business due to lower than expected reported attritional losses, compared to $29.7 million for the three months ended September 30, 2024 primarily driven by favorable development within Property business.
Core Services Results
Services revenues increased to $58.5 million for the three months ended September 30, 2025 compared to $48.1 million for the three months ended September 30, 2024 due to growth in the IMG travel business.
Net services income increased to $10.1 million for the three months ended September 30, 2025 compared to $7.0 million during the three months ended September 30, 2024, primarily driven by growth in IMG’s travel business. Service margin, which is calculated as Net service fee income as a percentage of services revenues, increased to 17.1% for the three months ended September 30, 2025 from 14.1% for the three months ended September 30, 2024 driven by enhanced profitability at both IMG through the travel program as well as Armada.
The following tables set forth the operating segment results and ratios for the nine months ended September 30, 2025 and 2024:
($ in millions)
| Nine months ended September 30, 2025 Insurance & Services | Reinsurance | Core | Eliminations (2) | Corporate | Segment Measure Reclass | Total | |
|---|---|---|---|---|---|---|---|
| Gross premiums written | $1,757.5 | $1,034.1 | $2,791.6 | $— | $15.7 | $— | $2,807.3 |
| Net premiums written | 1,273.1 | 843.6 | 2,116.7 | — | 1.0 | — | 2,117.7 |
| Net premiums earned | 1,086.6 | 828.3 | 1,914.9 | — | 11.5 | — | 1,926.4 |
| Loss and loss adjustment expenses incurred, net | 644.4 | 497.2 | 1,141.6 | (5.0) | 10.7 | — | 1,147.3 |
| Acquisition costs, net | 283.5 | 202.3 | 485.8 | (83.1) | 7.7 | — | 410.4 |
| Other underwriting expenses | 61.4 | 60.4 | 121.8 | — | 11.2 | — | 133.0 |
| Underwriting income (loss) | 97.3 | 68.4 | 165.7 | 88.1 | (18.1) | — | 235.7 |
| Services revenues | 178.7 | — | 178.7 | (94.6) | — | (84.1) | — |
| Services expenses | 141.2 | — | 141.2 | — | — | (141.2) | — |
| Net services fee income | 37.5 | — | 37.5 | (94.6) | — | 57.1 | — |
| Services noncontrolling loss | 0.2 | — | 0.2 | — | — | (0.2) | — |
| Net services income | 37.7 | — | 37.7 | (94.6) | — | 56.9 | — |
| Segment income (loss) | $135.0 | $68.4 | $203.4 | $(6.5) | $(18.1) | $56.9 | $235.7 |
| Attritional losses | $661.3 | $470.1 | $1,131.4 | $(5.0) | $5.3 | $— | $1,131.7 |
| Catastrophe losses | 4.8 | 62.6 | 67.4 | — | — | — | 67.4 |
| Prior year loss reserve development | (21.7) | (35.5) | (57.2) | — | 5.4 | — | (51.8) |
| Loss and loss adjustment expenses incurred, net | $644.4 | $497.2 | $1,141.6 | $(5.0) | $10.7 | $— | $1,147.3 |
| Underwriting Ratios: (1) | |||||||
| Attritional loss ratio | 60.9% | 56.7% | 59.1% | 58.8% | |||
| Catastrophe loss ratio | 0.4% | 7.6% | 3.5% | 3.5% | |||
| Prior year loss development ratio | (2.0)% | (4.3)% | (3.0)% | (2.7)% | |||
| Loss ratio | 59.3% | 60.0% | 59.6% | 59.6% | |||
| Acquisition cost ratio | 26.1% | 24.4% | 25.4% | 21.3% | |||
| Other underwriting expenses ratio | 5.7% | 7.3% | 6.4% | 6.9% | |||
| Combined ratio | 91.1% | 91.7% | 91.4% | 87.8% |
(1) Underwriting ratios are calculated by dividing the related expense by net premiums earned.
(2) Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.
($ in millions)
| Nine months ended September 30, 2024 Insurance & Services | Reinsurance | Core | Eliminations (2) | Corporate | Segment Measure Reclass | Total | |
|---|---|---|---|---|---|---|---|
| Gross premiums written | $1,390.5 | $1,023.4 | $2,413.9 | $— | $71.2 | $— | $2,485.1 |
| Net premiums written | 913.5 | 867.2 | 1,780.7 | — | 6.4 | — | 1,787.1 |
| Net premiums earned | 838.3 | 779.2 | 1,617.5 | — | 135.7 | — | 1,753.2 |
| Loss and loss adjustment expenses incurred, net | 538.8 | 406.0 | 944.8 | (4.1) | 58.7 | — | 999.4 |
| Acquisition costs, net | 206.9 | 206.8 | 413.7 | (93.8) | 62.4 | — | 382.3 |
| Other underwriting expenses | 55.4 | 59.9 | 115.3 | — | 12.5 | — | 127.8 |
| Underwriting income | 37.2 | 106.5 | 143.7 | 97.9 | 2.1 | — | 243.7 |
| Services revenues | 171.3 | — | 171.3 | (101.4) | — | (69.9) | — |
| Services expenses | 135.0 | — | 135.0 | — | — | (135.0) | — |
| Net services fee income | 36.3 | — | 36.3 | (101.4) | — | 65.1 | — |
| Services noncontrolling income | (2.1) | — | (2.1) | — | — | 2.1 | — |
| Net services income | 34.2 | — | 34.2 | (101.4) | — | 67.2 | — |
| Segment income | $71.4 | $106.5 | $177.9 | $(3.5) | $2.1 | $67.2 | $243.7 |
| Attritional losses | $546.3 | $424.9 | $971.2 | $(4.1) | $86.7 | $— | $1,053.8 |
| Catastrophe losses | 1.9 | 14.3 | 16.2 | — | — | — | 16.2 |
| Prior year loss reserve development | (9.4) | (33.2) | (42.6) | — | (28.0) | — | (70.6) |
| Loss and loss adjustment expenses incurred, net | $538.8 | $406.0 | $944.8 | $(4.1) | $58.7 | $— | $999.4 |
| Underwriting Ratios: (1) | |||||||
| Attritional loss ratio | 65.2% | 54.6% | 60.0% | 60.1% | |||
| Catastrophe loss ratio | 0.2% | 1.8% | 1.0% | 0.9% | |||
| Prior year loss development ratio | (1.1)% | (4.3)% | (2.6)% | (4.0)% | |||
| Loss ratio | 64.3% | 52.1% | 58.4% | 57.0% | |||
| Acquisition cost ratio | 24.7% | 26.5% | 25.6% | 21.8% | |||
| Other underwriting expenses ratio | 6.6% | 7.7% | 7.1% | 7.3% | |||
| Combined ratio | 95.6% | 86.3% | 91.1% | 86.1% |
(1) Underwriting ratios are calculated by dividing the related expense by net premiums earned.
(2) Insurance & Services MGAs recognize fees for service using revenue from contracts with customers accounting standards, whereas insurance companies recognize acquisition expenses using insurance contract accounting standards. While ultimate revenues and expenses recognized will match, there will be recognition timing differences based on the different accounting standards.
Core Premium Volume
Gross premiums written increased by $377.7 million, or 15.6%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. Net premiums written increased by $336.0 million, or 18.9%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. Net premiums earned increased by $297.4 million, or 18.4%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The increases in premium volume were primarily driven by our Insurance & Services segment, including growth across A&H, expansion of Surety within our Other Specialties business line, continued strategic organic and new program growth in our international business.
Core Underwriting Results
The improvement in net underwriting results of $22.0 million for the nine months ended September 30, 2025 in comparison to the nine months ended September 30, 2024 was primarily driven by premium growth combined with improved attritional loss and acquisition cost ratios. The improved attritional and acquisition cost ratios resulted in an additional income of $21.1 million for the nine months ended September 30, 2025 while there was a $14.6 million increase in favorable prior year loss reserve development, offset by $51.2 million increase in catastrophe losses driven by the California wildfires.
Core Services Results
Services revenues increased to $178.7 million for the nine months ended September 30, 2025 compared to $171.3 million for the nine months ended September 30, 2024 primarily due to growth in IMG’s travel business, offset by the effects of the Arcadian deconsolidation.
Net services fee income increased to $37.5 million for the nine months ended September 30, 2025 from $36.3 million for the nine months ended September 30, 2024 also driven by growth in IMG’s travel business. Service margin, which is calculated as net service fee income as a percentage of services revenues, decreased to 21.0% for the nine months ended September 30, 2025 compared to 21.2% for the nine months ended September 30, 2024.
We generated net services income of $37.7 million for the nine months ended September 30, 2025, compared to $34.2 million for the nine months ended September 30, 2024, primarily driven by growth in IMG’s travel business and offset by the deconsolidation of Arcadian, which generated net services income of $5.2 million for the nine months ended September 30, 2024.
Insurance & Services Segment
Through the Insurance & Services segment, we underwrite primary insurance in a number of sectors. With deep expertise and global reach, we offer innovative insurance solutions to meet the changing risk circumstances of our clients every day. The Insurance & Services segment includes Accident & Health, Property & Casualty, and Other Specialties.
As of September 30, 2025, we have equity stakes in 20 entities (MGAs, Insurtech and Other), which underwrite or distribute a wide range of lines of business, including general liability, professional liability, directors & officers, credit and bond, cyber, commercial automobile, workers’ compensation, accident & health, and other specialty insurance classes. As of September 30, 2025, we consolidated three MGAs in our financial statements: ArmadaCorp Capital, LLC (“Armada”), Alta Signa Holdings (“Alta Signa”) and IMG. Effective June 30, 2024, we deconsolidated Arcadian when our management and Arcadian consented to certain amendments to the shareholders’ agreement and termination of the unsecured promissory note which resulted in our Company ceasing to have control over Arcadian. There has been no change to our underwriting relationship with Arcadian. We provide underwriting capacity in the form of insurance or reinsurance to 10 non-consolidated entities in addition to the three consolidated MGAs. We also have investment stakes in 7 other entities where we have no underwriting relationships. The investment interests in the non-consolidated entities are included in strategic investments within Other long term investments on the consolidated balance sheet.
The following table sets forth underwriting results, net MGA results, and ratios for the segment results, and the period over period changes, for the three and nine months ended September 30, 2025 and 2024:
($ in millions)
| Three months ended September 30, 2025 | September 30, 2024 | Change | Nine months ended September 30, 2025 | September 30, 2024 | Change | |
|---|---|---|---|---|---|---|
| Gross premiums written | $562.0 | $376.0 | $186.0 | $1,757.5 | $1,390.5 | $367.0 |
| Net premiums written | 396.8 | 235.3 | 161.5 | 1,273.1 | 913.5 | 359.6 |
| Net premiums earned | 381.2 | 276.9 | 104.3 | 1,086.6 | 838.3 | 248.3 |
| Loss and loss adjustment expenses incurred, net | 225.3 | 170.1 | 55.2 | 644.4 | 538.8 | 105.6 |
| Acquisition costs, net | 98.3 | 65.9 | 32.4 | 283.5 | 206.9 | 76.6 |
| Other underwriting expenses | 19.9 | 20.0 | (0.1) | 61.4 | 55.4 | 6.0 |
| Underwriting income | 37.7 | 20.9 | 16.8 | 97.3 | 37.2 | 60.1 |
| Services revenues | 58.5 | 48.1 | 10.4 | 178.7 | 171.3 | 7.4 |
| Services expenses | 48.5 | 41.3 | 7.2 | 141.2 | 135.0 | 6.2 |
| Net services fee income | 10.0 | 6.8 | 3.2 | 37.5 | 36.3 | 1.2 |
| Services noncontrolling (income) loss | 0.1 | 0.2 | (0.1) | 0.2 | (2.1) | 2.3 |
| Net services income | 10.1 | 7.0 | 3.1 | 37.7 | 34.2 | 3.5 |
| Segment income | $47.8 | $27.9 | $19.9 | $135.0 | $71.4 | $63.6 |
| Underwriting ratios: (1) | ||||||
| Loss ratio | 59.1% | 61.4% | (2.3)% | 59.3% | 64.3% | (5.0)% |
| Acquisition cost ratio | 25.8% | 23.8% | 2.0% | 26.1% | 24.7% | 1.4% |
| Other underwriting expense ratio | 5.2% | 7.2% | (2.0)% | 5.7% | 6.6% | (0.9)% |
| Combined ratio | 90.1% | 92.4% | (2.3)% | 91.1% | 95.6% | (4.5)% |
(1) Underwriting ratios are calculated by dividing the related expense by net premiums earned.
Premium Volume
Gross premiums written increased by $186.0 million, or 49.5%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024, primarily driven by growth across Life, Accident & Health, expansion of Surety within our Other Specialties business line, growth across A&H, and continued strategic organic and new program growth in our international business, specifically London MGAs.
Gross premiums written increased by $367.0 million, or 26.4%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, primarily driven by Life, Accident & Health, expansion of Surety within our Other Specialties business line, and continued strategic organic and new program growth in our international business, specifically London MGAs.
Consolidated MGAs
Gross premiums written by the consolidated MGAs in the aggregate increased by $16.1 million, or 27.3%, to $75.0 million for the three months ended September 30, 2025 compared to $58.9 million for the three months ended September 30, 2024, primarily resulting from growth from IMG.
Gross premiums written generated by the consolidated MGAs in the aggregate increased by $42.9 million, or 21.4%, to $243.0 million for the nine months ended September 30, 2025 compared to $200.1 million for the nine months ended September 30, 2024, primarily resulting from the growth from IMG.
Book value for the consolidated MGAs was $90.8 million as of September 30, 2025, compared to $90.1 million as of December 31, 2024. The increase in book value from December 31, 2024 was the result of income in the period offset by intercompany dividends used to fund the share repurchase.
Underwriting Results
The improvement in underwriting income of $16.8 million for the three months ended September 30, 2025 compared to the three months ended September 30, 2024 was primarily driven by a lower attritional loss ratio, partially offset by slightly lower prior year loss reserve development of $9.5 million for the three months ended September 30, 2025, mainly in A&H, compared to net favorable prior year loss reserve development of $13.1 million for the three months ended September 30, 2024.
The improvement in underwriting income of $60.1 million for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 was primarily driven by growth combined with an improving attritional loss ratio as well as net favorable prior year loss reserve development of $21.7 million for the nine months ended September 30, 2025, mainly in A&H, compared to net favorable prior year loss reserve development of $9.4 million for the nine months ended September 30, 2024.
Services Results
The increase in services revenues of $10.4 million for the three months ended September 30, 2025 compared to the three months ended September 30, 2024 was primarily due to growth in the IMG travel business.
The increase in services revenues of $7.4 million for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 was primarily due to growth in IMG’s travel business. Excluding Arcadian, service revenues increased by $20.4 million for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024.
Net services income increased to $10.1 million for the three months ended September 30, 2025 compared to $7.0 million during the three months ended September 30, 2024, primarily driven by growth in IMG’s travel business.
Net services income increased to $37.7 million for the nine months ended September 30, 2025 compared to $34.2 million during the nine months ended September 30, 2024, primarily driven by growth in IMG’s travel business and offset by the deconsolidation of Arcadian which generated net services income of $5.2 million for the nine months ended September 30, 2024.
Reinsurance Segment
The Reinsurance segment predominantly underwrites Casualty, Property and Other Specialties lines of business on a worldwide basis. The following table sets forth underwriting results and ratios, and the period over period changes for the Reinsurance segment, for the three and nine months ended September 30, 2025 and 2024:
($ in millions)
| Three months ended September 30, 2025 | September 30, 2024 | Change | Nine months ended September 30, 2025 | September 30, 2024 | Change | |
|---|---|---|---|---|---|---|
| Gross premiums written | $309.6 | $314.5 | $(4.9) | $1,034.1 | $1,023.4 | $10.7 |
| Net premiums written | 268.1 | 268.3 | (0.2) | 843.6 | 867.2 | (23.6) |
| Net premiums earned | 262.3 | 269.4 | (7.1) | 828.3 | 779.2 | 49.1 |
| Loss and loss adjustment expenses incurred, net | 145.5 | 137.6 | 7.9 | 497.2 | 406.0 | 91.2 |
| Acquisition costs, net | 64.7 | 69.8 | (5.1) | 202.3 | 206.8 | (4.5) |
| Other underwriting expenses | 20.2 | 20.4 | (0.2) | 60.4 | 59.9 | 0.5 |
| Underwriting income | $31.9 | $41.6 | $(9.7) | $68.4 | $106.5 | $(38.1) |
| Underwriting ratios: (1) | ||||||
| Loss ratio | 55.5% | 51.1% | 4.4% | 60.0% | 52.1% | 7.9% |
| Acquisition cost ratio | 24.7% | 25.9% | (1.2)% | 24.4% | 26.5% | (2.1)% |
| Other underwriting expense ratio | 7.7% | 7.6% | 0.1% | 7.3% | 7.7% | (0.4)% |
| Combined ratio | 87.9% | 84.6% | 3.3% | 91.7% | 86.3% | 5.4% |
(1) Underwriting ratios are calculated by dividing the related expense by net premiums earned.
Premium Volume
Gross premiums written in the Reinsurance segment decreased by $4.9 million, or 1.6%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024, primarily driven by slight decreases in Aviation and International Credit offset by growth in Bermuda Specialty.
Gross premiums written in the Reinsurance segment increased by $10.7 million, or 1.0%, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, primarily driven by growth in Bermuda Specialty and reinstatement premiums of $8.9 million related to Property Catastrophe business offset by decreases in Aviation.
Underwriting Results
The decrease in net underwriting results for the three months ended September 30, 2025 compared to the three months ended September 30, 2024 was the result of a decrease in favorable prior year development of $17.0 million offset by a decrease in catastrophe losses of $11.3 million .
The decrease in net underwriting results for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, was primarily driven by increased catastrophe losses of $62.6 million or 7.6 percentage points on the combined ratio, primarily from the California wildfires, compared to $14.3 million, or 1.8 percentage points on the combined ratio, for the nine months ended September 30, 2024. Favorable prior year loss reserve development was relatively flat and was $35.5 million for the nine months ended September 30, 2025, primarily driven by favorable development in Property, mainly from reserve releases relating to prior year’s catastrophe events, compared to $33.2 million for the nine months ended September 30, 2024 primarily driven by decreased ultimate losses in the Credit reinsurance portfolio.
Corporate
Corporate includes the results of all runoff business, which represents certain classes of business that we no longer actively underwrite, including the effects of the restructuring of the underwriting platform announced in 2022 and certain reinsurance contracts that have interest crediting features. Corporate results also include asbestos and environmental and other latent liability exposures on a gross basis, which have mostly been ceded, as well as specific workers’ compensation and cyber programs which we no longer write. The following table sets forth underwriting results and the period over period changes for the three and nine months ended September 30, 2025 and 2024:
($ in millions)
| Three months ended September 30, 2025 | September 30, 2024 | Change | Nine months ended September 30, 2025 | September 30, 2024 | Change | |
|---|---|---|---|---|---|---|
| Gross premiums written | $2.8 | $23.5 | $(20.7) | $15.7 | $71.2 | $(55.5) |
| Net premiums written | 5.4 | 0.6 | 4.8 | 1.0 | 6.4 | (5.4) |
| Net premiums earned | 4.2 | 22.6 | (18.4) | 11.5 | 135.7 | (124.2) |
| Loss and loss adjustment expenses incurred, net | 3.6 | 11.2 | (7.6) | 10.7 | 58.7 | (48.0) |
| Acquisition costs, net | 3.7 | 5.9 | (2.2) | 7.7 | 62.4 | (54.7) |
| Other underwriting expenses | 3.5 | 4.5 | (1.0) | 11.2 | 12.5 | (1.3) |
| Underwriting income (loss) | $(6.6) | $1.0 | $(7.6) | $(18.1) | $2.1 | $(20.2) |
The changes in premium volume for the three and nine months ended September 30, 2025 were primarily driven by the decreases in business from specific workers’ compensation and cyber programs that were placed in runoff in the first quarter of 2024 and are expected to have limited volume in 2025. Gross premium volume decreases were partially offset by premiums from a fronting agreement during the three and nine months ended September 30, 2025.
The underwriting loss for the three months ended September 30, 2025 compared to underwriting income for the three months ended September 30, 2024 was primarily the result of decreased underwriting activity following the runoff of existing portfolios.
The underwriting loss for the nine months ended September 30, 2025 compared to underwriting income for the nine months ended September 30, 2024 was the result of an increase in reported losses on legacy international property contracts.
Liquidity and Capital Resources
Liquidity Requirements
Liquidity is a measure of a company’s ability to generate cash flows sufficient to meet short-term and long-term cash requirements of its business operations. SiriusPoint’s insurance and reinsurance operations are subject to regulation and supervision in each of the jurisdictions where they are domiciled and licensed to conduct business. Generally, regulatory authorities have broad supervisory and administrative powers over such matters as licenses, standards of solvency, premium rates, policy forms, investments, security deposits, methods of accounting, form and content of financial statements, reserves for unpaid loss and loss adjustment expenses, reinsurance, minimum capital and surplus requirements, dividends and other distributions to shareholders, periodic examinations and annual and other report filings. In general, such regulation is for the protection of policyholders rather than shareholders. SiriusPoint manages its liquidity needs primarily through the maintenance of a short duration and high quality fixed income portfolio.
SiriusPoint is a holding company and has no substantial operations of its own and its assets consist primarily of its investments in subsidiaries. Its cash needs primarily consist of the payment of corporate expenses, interest payments on senior and subordinated notes, investment opportunities and dividends to preference shareholders. SiriusPoint may also require cash to fund share repurchases. Cash at the subsidiaries is used primarily to pay loss and loss adjustment expenses, reinsurance premiums, acquisition costs, interest expense, taxes, general and administrative expenses and to purchase investments. The insurance and reinsurance business of our operating subsidiaries inherently provide liquidity, as premiums are received in advance of the time losses are paid. However, the amount of cash required to fund loss payments can fluctuate significantly from period to period, due to the low frequency/high severity nature of certain types of business we write.
For additional commitments and contingencies that may affect our liquidity requirements see Note 18 “Commitments and contingencies” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Dividend Capacity and Capital
We are subject to regulatory and other constraints that affect our ability to pay dividends. During the three and nine months ended September 30, 2025, SiriusPoint declared and paid dividends of $4.0 million and $12.0 million, respectively, to the Series B preference shareholders (2024 - $4.0 million and $12.0 million, respectively). During the three and nine months ended September 30, 2025, SiriusPoint did not pay any dividends to its common shareholders.
For the three and nine months ended September 30, 2025, SiriusPoint received $17.0 million and $452.0 million, respectively (2024 - $283.0 million and $428.0 million, respectively) of distributions from SiriusPoint Bermuda Insurance Company Ltd. (“SiriusPoint Bermuda”), its immediate wholly-owned subsidiary. We believe the dividend/distribution capacity of SiriusPoint’s subsidiaries, which was approximately $712.7 million as of December 31, 2024, provides SiriusPoint with sufficient liquidity for the foreseeable future. For a further discussion of the various restrictions on SiriusPoint Bermuda’s ability to pay dividends, see Part I, Item 1 “Business - Regulation” in our 2024 Form 10-K.
In addition to the regulatory and other contractual constraints to paying dividends, we manage the capital of the group and each of our operating subsidiaries to support our current ratings from AM Best, Fitch, S&P and Moody’s. This could further reduce the ability and amount of dividends that could be paid from subsidiaries to SiriusPoint. In addition, the Company annually files the prescribed form of capital and solvency return, which comprises the insurer’s Bermuda Solvency Capital Requirement (“BSCR”) model. The BSCR model is a risk-based capital model which provides a method for determining a Class 3A and Class 4 insurer’s capital requirements (statutory economic capital and surplus) by taking into account the risk characteristics of different aspects of the Class 3A and Class 4 insurer’s business. Our 2024 filed BSCR ratio was 228%. We are also currently completing our third quarter 2025 Bermuda Quarterly Financial Return, with an estimated ratio of 226%.
Sources of Liquidity
Our operating subsidiaries sources of liquidity have primarily consisted of net premiums written, reinsurance recoveries, investment income and proceeds from sales of or dividends or distributions attributable to investments. Other potential sources of liquidity include borrowings under our credit facilities, the Federal Home Loan Bank of New York (“FHLBNY”) advance program and issuances of securities.
Effective December 19, 2024, we entered into a four-year, $400.0 million senior unsecured revolving credit facility (the “Facility”) with JPMorgan Chase Bank, N.A. as administrative agent. The Facility includes an option for the Company to request a 12-month extension, subject to satisfaction of certain conditions including, but not limited to, the consent of lenders representing a majority-in-interest of commitments, of the Facility maturity date. Subject to customary conditions precedent upon any borrowing request, the Facility provides access to loans for working capital and general corporate purposes, as well as letters of credit to support obligations under insurance and reinsurance agreements, retrocessional agreements and for general corporate purposes. As of September 30, 2025, the Company was in compliance with all of the covenants under the Facility and there were no outstanding borrowings under the Facility.
Effective September 2025, we became a member of the FHLBNY. As a member, we may borrow through the advance program of the FHLBNY. The FHLBNY advance program provides short- and long-term, fully collateralized loans, called advances, to their members. We have the ability to obtain this funding based on a percentage of the value of our admitted assets in the State of New York, subject to availability of eligible collateral. As of September 30, 2025, there were no outstanding FHLBNY borrowings.
Financing
We expect that our cash and cash equivalents on the balance sheet and cash flow from operations will provide us with the financial flexibility to execute our strategic objectives. Our ability to generate cash, however, is subject to our performance, general economic conditions, industry trends and other factors. To the extent cash and cash equivalents on the balance sheet, investment returns and cash flow from operations are insufficient to fund our future activities and requirements, we may need to raise additional funds through public or private equity or debt financing. If we issue equity securities in order to raise additional funds, substantial dilution to existing shareholders may occur. If we raise cash through the issuance of additional indebtedness, we may be subject to additional contractual restrictions on our business. There is no assurance that we would be able to raise the additional funds on favorable terms or at all.
The following table represents a summary of our debt obligations as of September 30, 2025 and December 31, 2024:
| September 30, 2025 Amount | Effective rate (1) | December 31, 2024 Amount | Effective rate (1) | |
|---|---|---|---|---|
| 2024 Senior Notes, at face value | $400.0 | 7.4% | $400.0 | 7.4% |
| Unamortized discount and issuance costs | (4.3) | (5.2) | ||
| 2024 Senior Notes, carrying value | 395.7 | 394.8 | ||
| 2017 SEK Subordinated Notes, at face value | 292.4 | 7.1% | 249.2 | 7.9% |
| Unamortized discount | (5.6) | (4.9) | ||
| 2017 SEK Subordinated Notes, carrying value | 286.8 | 244.3 | ||
| Total debt | $682.5 | $639.1 |
(1) Effective rate considers the effect of the debt issuance costs, discount, and premium.
For further details and discussion with respect to the 2024 Senior Notes and 2017 SEK Subordinated Notes, please refer to Note 14 “Debt and letter of credit facilities” of Part II, Item 8. “Financial Statements and Supplementary Data” included in our 2024 Form 10-K.
Debt Covenants
As of September 30, 2025, we were in compliance with all of the covenants under the 2024 Senior Notes and the 2017 SEK Subordinated Notes.
Series B Preference Shares
We have 8,000,000 of Series B preference shares outstanding, par value $0.10, which are listed on the New York Stock Exchange under the symbol “SPNT PB.” Dividends on the Series B preference shares are cumulative and payable quarterly in arrears at an initial rate of 8.0%.
As of September 30, 2025, the carrying value of the Series B preference shares was $200.0 million and reflected in shareholders’ equity attributable to SiriusPoint shareholders in the consolidated balance sheets. During the three and nine months ended September 30, 2025, the Company declared and paid dividends of $4.0 million and $12.0 million, respectively, to the Series B preference shareholders. The Company has declared and paid dividends to the Series B preference shareholders every quarter beginning June 30, 2021.
For further details and discussion with respect to the Series B preference shares, see Note 15 “Shareholders' equity” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Letter of Credit Facilities
As of September 30, 2025, letters of credit in the amount of $1,077.3 million had been issued by the Company to various insurance and reinsurance counterparties. Each of the facilities contain customary events of default and restrictive covenants, including but not limited to, limitations on liens on collateral, transactions with affiliates, mergers and sales of assets, as well as solvency and maintenance of certain minimum pledged equity requirements and a minimum rating from rating agencies. Each restricts issuance of any debt without the consent of the letter of credit provider. Additionally, if an event of default exists under any of the letter of credit facilities, our subsidiaries could be prohibited from paying dividends. We were in compliance with all of the covenants under the aforementioned letter of credit facilities as of September 30, 2025.
For further details and discussion with respect to letter of credit facilities, see Note 13 “Debt and letter of credit facilities” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Cash Secured Letter of Credit Agreements
Under the cash secured letter of credit facilities, we provide collateral that consists of cash and cash equivalents and debt securities. As of September 30, 2025, total cash and cash equivalents and debt securities with a fair value of $1,298.5 million were pledged as collateral against the letters of credit issued.
We believe that we have adequate capacity between our existing cash secured letter of credit agreements as well as available investments to post in reinsurance trusts to meet our collateral obligations under our existing and future reinsurance business.
For further details and discussion with respect to cash secured letter of credit agreements, see Note 13 “Debt and letter of credit facilities” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Cash, Restricted Cash and Cash Equivalents and Restricted Investments
Cash and cash equivalents consist of cash held in banks and other short-term, highly liquid investments with original maturity dates of 90 days or less. We invest a portion of the collateral securing certain reinsurance contracts in U.S. treasury securities and sovereign debt. This portion of the collateral is included in debt securities in the consolidated balance sheets and is disclosed as part of restricted investments. In addition, restricted investments also pertain to limited partnership interests in Third Point funds securing the Company’s contractual obligations under certain reinsurance contracts that the Company will not be released from until the underlying risks have expired or have been settled.
Restricted cash and cash equivalents and restricted investments decreased to $2,297.8 million as of September 30, 2025 from $2,427.6 million as of December 31, 2024.
For additional information on restricted cash, cash equivalents and investments, see Note 5 “Cash, cash equivalents, restricted cash and restricted investments” in our unaudited consolidated financial statements included elsewhere in this Form 10-Q.
Cash Flows
Our cash flows from operations generally represent the difference between: (1) premiums collected and investment income and (2) loss and loss expenses paid, reinsurance purchased, underwriting and other expenses paid. Cash flows from operations may differ substantially from net income and may be volatile from period to period depending on the underwriting opportunities available to us and other factors. Due to the nature of our underwriting portfolio, claim payments can be unpredictable and may need to be made within relatively short periods of time. Claim payments can also be required several months or years after premiums are collected. In addition, as discussed above, SiriusPoint has access to the $400.0 million Facility that provides access to loans for working capital and general corporate purposes, and letters of credit to support obligations under insurance and reinsurance agreements and retrocessional agreements.
Operating, investing and financing cash flows for the nine months ended September 30, 2025 and 2024 were as follows:
($ in millions)
| 2025 | 2024 | |
|---|---|---|
| Net cash provided by (used in) operating activities | $128.8 | $(33.0) |
| Net cash provided by investing activities | 234.9 | 140.4 |
| Net cash used in financing activities | (517.0) | (393.5) |
| Net decrease in cash, cash equivalents and restricted cash | (153.3) | (286.1) |
| Cash, cash equivalents and restricted cash at beginning of period | 894.6 | 1,101.3 |
| Change in cash, cash equivalents and restricted cash classified as assets held for sale | (23.6) | — |
| Cash, cash equivalents and restricted cash at end of period | $717.7 | $815.2 |
Operating Activities
Cash flows provided by operating activities can fluctuate due to timing differences between the collection of premiums and reinsurance recoverables, the payment of losses and loss expenses, and the payment of premiums to reinsurers. The change in cash flows in operating activities for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 was primarily driven by an increase in the collection of premiums consistent with the underlying growth of the business, offset by payments related to California wildfire claims.
Investing Activities
Cash flows provided by investing activities for the nine months ended September 30, 2025 were driven by higher proceeds from sales and maturities of debt securities compared to purchases during the period. Cash flows provided by investing activities for the nine months ended September 30, 2024 were driven by changes in our investment portfolio, primarily purchases and sales of fixed income and short-term investments.
Financing Activities
Cash flows used in financing activities for the nine months ended September 30, 2025 primarily consisted of $490.8 million in payments for share repurchases. Cash flows used in financing activities for the nine months ended September 30, 2024 primarily consisted of a $517.9 million payment for the redemption of debt and $98.2 million net payments on deposit liability contracts, offset by $393.9 million of proceeds from the issuance of debt, net of costs and $18.5 million of proceeds from the exercise of options.
Non-GAAP Financial Measures
We have included certain financial measures that are not calculated under standards or rules that comprise U.S. GAAP. Such measures, including Core underwriting income, Core net services income, Core income, Core combined ratio, accident year loss ratio, accident year combined ratio, attritional loss ratio and tangible book value per diluted common share, are referred to as non-GAAP financial measures. These non-GAAP financial measures may be defined or calculated differently by other companies. We believe these measures allow for a more complete understanding of our underlying business. These measures are used by management to monitor our results and should not be viewed as a substitute for those determined in accordance with U.S. GAAP. Reconciliations of non-GAAP measures to the most comparable U.S. GAAP measures are included below.
Core Results
Collectively, the sum of the Company's two segments, Insurance & Services and Reinsurance, constitute "Core" results. Core underwriting income, Core net services income, Core income and Core combined ratio are non-GAAP financial measures. We believe it is useful to review Core results as it better reflects how management views the business and reflects our decision to exit the runoff business. The sum of Core results and Corporate results are equal to the consolidated results of operations.
Core underwriting income - calculated by subtracting loss and loss adjustment expenses incurred, net, acquisition costs, net, and other underwriting expenses from net premiums earned.
Core net services income - consists of services revenues which include commissions, brokerage and fee income related to consolidated MGAs, and other revenues, as well as services expenses which include direct expenses related to consolidated
MGAs and services noncontrolling income which represent minority ownership interests in consolidated MGAs. Net services income is a key indicator of the profitability of the Company's services provided.
Core income - consists of two components, core underwriting income and core net services income. Core income is a key measure of our segment performance.
Core combined ratio - calculated by dividing the sum of Core loss and loss adjustment expenses incurred, net, acquisition costs, net and other underwriting expenses by Core net premiums earned. Accident year loss ratio and accident year combined ratio are calculated by excluding prior year loss reserve development to present the impact of current accident year net loss and loss adjustment expenses on the Core loss ratio and Core combined ratio, respectively. Attritional loss ratio excludes catastrophe losses from the accident year loss ratio as they are not predictable as to timing and amount. These ratios are useful indicators of our underwriting profitability.
See Note 4 “Segment reporting” to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information and a calculation of Core results.
Tangible Book Value Per Diluted Common Share
Tangible book value per diluted common share, as presented, is a non-GAAP financial measure and the most directly comparable U.S. GAAP measure is book value per common share. Tangible book value per diluted common share excludes intangible assets. Management believes that effects of intangible assets are not indicative of underlying underwriting results or trends and make book value comparisons to less acquisitive peer companies less meaningful. Tangible book value per diluted common share is useful because it provides a more accurate measure of the realizable value of shareholder returns, excluding intangible assets.
The following table sets forth the computation of book value per common share, book value per diluted common share and tangible book value per diluted common share as of September 30, 2025 and December 31, 2024:
($ in millions, except share and per share amounts)
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Common shareholders’ equity attributable to SiriusPoint common shareholders | $2,009.9 | $1,737.4 |
| Intangible assets | 123.6 | 140.8 |
| Tangible common shareholders' equity attributable to SiriusPoint common shareholders | $1,886.3 | $1,596.6 |
| Common shares outstanding | 116,807,497 | 116,429,057 |
| Effect of dilutive stock options, restricted share units and warrants | 2,034,652 | 2,559,359 |
| Book value per diluted common share denominator | 118,842,149 | 118,988,416 |
| Book value per common share | $17.21 | $14.92 |
| Book value per diluted common share | $16.91 | $14.60 |
| Tangible book value per diluted common share | $15.87 | $13.42 |
Financial Condition
As of September 30, 2025, total shareholders’ equity was $2,211.0 million, compared to $1,938.8 million as of December 31, 2024. The increase was due to net income of $203.6 million and accumulated other comprehensive income from unrealized gains from AFS debt securities of $54.0 million for the nine months ended September 30, 2025.
Contractual Obligations
There have been no material changes to our contractual obligations from our 2024 Form 10-K.
Critical Accounting Policies and Estimates
For a summary of our significant accounting and reporting policies, please refer to Note 2 “Significant accounting policies” of Part II, Item 8. “Financial Statements and Supplementary Data” included in our 2024 Form 10-K.
Our consolidated financial statements are prepared in accordance with U.S. GAAP, which requires management to make estimates and assumptions. As of December 31, 2024, the accounting policies that required the most significant judgments and estimations by management were: (1) premium revenue recognition, (2) loss and loss adjustment expense reserves, (3) fair value measurements related to our investments and (4) income taxes. If actual events differ significantly from the underlying judgments or estimates used by management in the application of these accounting policies, there could be a material adverse effect on our results of operations and financial condition. Refer to Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in our 2024 Form 10-K.
Market risk
As filed, 4,364 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our consolidated balance sheets include a substantial amount of assets and liabilities whose fair values are subject to market risk. The term market risk refers to the risk of loss arising from adverse changes in interest rates, credit spreads, equity markets prices, and other relevant market rates and prices. Due to our sizable investment portfolio, market risk can have a significant effect on our consolidated financial position.
We believe we are principally exposed to the following types of market risk:
- interest rate risk; and
- foreign currency exchange risk.
Interest Rate Risk
Interest rate risk is the price sensitivity of a security to changes in interest rates. Our investment portfolio includes fixed income investments, whose fair values will fluctuate with changes in interest rates. Increases and decreases in prevailing interest rates generally translate into decreases and increases in fair values of fixed income investments, respectively. Additionally, fair values of interest rate sensitive instruments may be affected by the creditworthiness of the issuer, prepayment options, relative values of alternative investments, the liquidity of the instrument, and other market factors.
We manage the interest rate risk associated with our portfolio of fixed income investments by matching assets backing reserves with that of our economic liabilities, in addition to monitoring the average of investment-grade corporate securities; U.S. government and agency securities; foreign government, agency and provincial obligations; preferred stocks; asset-backed and mortgage-backed securities; and municipal obligations.
The following table summarizes the estimated effects of hypothetical increases and decreases in market interest rates on our debt securities as of September 30, 2025:
($ in millions)
| Fair value | Assumed change in interest rate | Estimated fair value after change in interest rate | Pre-tax increase (decrease) in carrying value | |
|---|---|---|---|---|
| Debt securities | $5,244.3 | 300 bp decrease | $5,648.0 | $403.7 |
| 200 bp decrease | 5,511.0 | 266.7 | ||
| 100 bp decrease | 5,374.0 | 129.7 | ||
| 50 bp decrease | 5,305.5 | 61.2 | ||
| 50 bp increase | 5,154.8 | (89.5) | ||
| 100 bp increase | 5,071.6 | (172.7) | ||
| 200 bp increase | 4,901.9 | (342.4) | ||
| 300 bp increase | 4,728.1 | (516.2) |
The magnitude of the fair value decrease in rising rates scenarios may be more significant than the fair value increase in comparable falling rates scenarios. This can occur because (i) the analysis floors interest rates at a de minimis level in falling rate scenarios, muting price increases, (ii) portions of the fixed income investment portfolio may be callable, muting price increases in falling interest rate scenarios and/or (iii) portions of the fixed income investment portfolio may experience cash flow extension in higher interest rate environments, which generally results in lower fixed income asset prices.
Interest payments on our 2017 SEK Subordinated Notes are required to be serviced in Swedish kronor by reference to Stockholm Interbank Offered Rate, a floating interest rate benchmark. This benchmark rate has decreased year to date and it is possible that it will continue to do so, which could result in changes to our interest expense.
Foreign Currency Exchange Risk
In the ordinary course of business, we hold non-U.S. dollar denominated assets and liabilities, which are valued using period-end exchange rates. Non-U.S. dollar denominated foreign revenues and expenses are valued using average exchange rates over the period. Foreign currency exchange-rate risk is the risk that we will incur losses on a U.S. dollar basis due to adverse changes in foreign currency exchange rates.
The following table summarizes the estimated effects of a hypothetical 10% increase and decrease in the value of the U.S. dollar against select foreign currencies would have had on the carrying value of our net assets as of September 30, 2025:
($ in millions)
| 10% increase | 10% decrease | |
|---|---|---|
| Swedish Krona to U.S. Dollar | $(0.5) | $0.5 |
| British Pound to U.S. Dollar | 0.1 | (0.1) |
| Swiss Franc to U.S. dollar | 0.6 | (0.6) |
| Euro to U.S. Dollar | (0.3) | 0.3 |
| Canadian Dollar to U.S. Dollar | $(0.7) | $0.7 |
Controls and procedures
As filed, 956 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended) as of September 30, 2025. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2025.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) that occurred during the three months ended September 30, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 2,966 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our business is subject to a number of risks, including those described in the Company’s risk factors disclosed in Part I, Item 1A of our 2024 Form 10-K, that may prevent us from achieving our business objectives or may adversely affect our business, financial condition, cash flows and results of operations.
We may be adversely impacted by inflation and the changing tariff landscape.
Economies around the world continue to experience heightened levels of inflation. Inflation can be caused by any number of factors including, but not limited to, expansionary monetary policy and deficit spending by the government, rising wages, an imbalance of the supply and demand for goods, supply chain disruptions and the imposition of tariffs. Recently, the U.S. administration imposed and/or announced (and in some cases postponed) tariffs on imports from various countries and on certain products, which may lead to retaliatory tariffs on U.S. exports, unpredictable economic consequences including inflation, trade wars and capital market volatility. In operating our business, we are continuing to experience the effects of inflation, along with potential further economic impact from the changing tariff landscape. Furthermore, our business, like those of other insurers and reinsurers, are susceptible to the effects of inflation because premiums are established before the ultimate amounts of losses and loss expenses are known. Although we consider the potential effects of inflation when setting premium rates, premiums may not fully offset the effects of inflation and thereby essentially result in underpricing the risks we insure and reinsure. Loss reserves include assumptions about future payments for settlement of claims and claims-handling expenses, such as the value of replacing property, associated labor costs for the property business we write and litigation costs. To the extent inflation causes costs to increase above loss reserves established for claims, we will be required to increase loss reserves with a corresponding reduction in net income in the period in which the deficiency is identified, which may have a material adverse effect on our results of operations or financial condition. Unanticipated higher inflation could lead to additional interest rate increases, which would negatively impact the value of our fixed income securities and potentially other investments. The changing tariff landscape may hinder economic growth that may in turn impact our credit and mortgage business. Heightened market volatility could lead to a rise in credit spread which could impact the company’s short-term capital and liquidity positions. To the extent higher inflation could lead to currency fluctuations, we may also experience increased volatility in foreign exchange gains and losses in our financial statements.
Except as otherwise set forth above, there have been no material changes to the risk factors disclosed in our 2024 Form 10-K.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-07-01 to 2025-09-30 | $755.9m | us-gaap:Revenues |
| Revenue | 9 months2025-01-01 to 2025-09-30 | $2.23bn | us-gaap:Revenues |
| Interest expense | 3 months2025-07-01 to 2025-09-30 | $21.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2025-01-01 to 2025-09-30 | $60.2m | us-gaap:InterestExpense |
| Income tax | 3 months2025-07-01 to 2025-09-30 | $20.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-01-01 to 2025-09-30 | $45.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-07-01 to 2025-09-30 | $90.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-01-01 to 2025-09-30 | $215.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-07-01 to 2025-09-30 | $0.73 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-01-01 to 2025-09-30 | $1.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-07-01 to 2025-09-30 | $0.74 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-01-01 to 2025-09-30 | $1.75 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-07-01 to 2025-09-30 | 118,817,903 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-01-01 to 2025-09-30 | 118,655,606 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-01-01 to 2025-09-30 | $128.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2025-01-01 to 2025-09-30 | $0 | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2025-01-01 to 2025-09-30 | $490.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-09-30 | $582.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2025-09-30 | $12.46bn | us-gaap:Assets |
| Total liabilities | At period end2025-09-30 | $10.25bn | us-gaap:Liabilities |
| Long-term debt | At period end2025-09-30 | $682.5m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2025-09-30 | $2.21bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001576018-25-000044. Last ingested by Listed: Nov 14, 2026, 12:43 ET. Listed shows no prices and gives no investment advice.